Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI   US72940R1023

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/22/2015 07/23/2015 07/24/2015 07/27/2015 07/28/2015 Date
2.29(c) 2.3(c) 2.29(c) 2.37(c) 2.39 Last
177 159 152 355 61 114 151 846 101 062 Volume
-2.55% +0.44% -0.43% +3.49% +0.84% Change
More quotes
Financials ($)
Sales 2015 0,38 M
EBIT 2015 -27,1 M
Net income 2015 -26,8 M
Debt 2015 -
Yield 2015 -
Sales 2016 0,30 M
EBIT 2016 -30,2 M
Net income 2016 -29,7 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 485x
Capi. / Sales 2016 612x
Capitalization 186 M
More Financials
Company
Pluristem Therapeutics, Inc. is a bio-therapeutic company, which develops standardized cell therapy products for the treatment of life threatening diseases.The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a... 
More about the company
Surperformance© ratings of Pluristem Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on PLURISTEM THERAPEUTICS INC
07/27 PLURISTEM THERAPEUTICS : New Data Show Pluristem's PLX Cells Regulate the Immune..
07/27 PLURISTEM THERAPEUTICS : New Data Show Pluristem’s PLX Cells Regulate the ..
07/27 New Data Show Pluristem's PLX Cells Regulate the Immune System
06/30 PLURISTEM THERAPEUTICS : Israel's Pluristem raises $17M to bring placental stem ..
06/26 PLURISTEM THERAPEUTICS : Granted Australian Patent for 3D Cell Expansion Technol..
06/26 PLURISTEM THERAPEUTICS : Announces Pricing of Registered Direct Offering of Comm..
06/25 PLURISTEM THERAPEUTICS : Entry into a Material Definitive Agreement, Financial S..
06/03 PLURISTEM THERAPEUTICS : Awarded Grant from Israel’s Ministry of Economy f..
More news
Sector news : Biotechnology & Medical Research - NEC
06:18a UNITED THERAPEUTICS : beats 2Q profit forecasts
06:01a UNITED THERAPEUTICS : Reports Second Quarter 2015 Financial Results
07/27 ALNYLAM PHARMACEUTICALS : Initiates Phase 1/2 Clinical Trial for ALN-AAT, an Inv..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/25 Pluristem prices equity offering
06/17 Pluristem awarded $2.9M grant to support R&D
05/28 Pluristem's PLX Cells Get Green Light For Fast Track Clinical Trials In Europ..
05/18 EMA picks Pluristem's PLX cells for accelerated approval program for critical..
05/18 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am


Comments 
Advertisement
Chart PLURISTEM THERAPEUTICS INC
Duration : Period :
Pluristem Therapeutics Inc Technical Analysis Chart | PSTI | US72940R1023 | 4-Traders
Full-screen chart
Technical analysis trends PLURISTEM THERAPE...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions